Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
William M Brown. (2007) Treating COPD with PDE 4 inhibitors. International Journal of Chronic Obstructive Pulmonary Disease 2:4, pages 517-533.
Read now
Read now
Sharon L Wolda. (2000) PDE4 inhibitors and chronic obstructive pulmonary disease. Emerging Drugs 5:3, pages 309-319.
Read now
Read now
Articles from other publishers (18)
Yun-Deng Wu, Xiao-Hong Liu, Jian Xu, Si-Han Zhang, Kun Shen, Ling Sun, Yong-Mei He, Yan Ma & Ai-Hua Zhang. (2017) Crystal structure of an apremilast ethanol hemisolvate hemihydrate solvatomorph. Acta Crystallographica Section E Crystallographic Communications 73:6, pages 821-824.
Crossref
Crossref
Yun-Deng Wu, Xiao-Lei Zhang, Xiao-Hong Liu, Jian Xu, Mei Zhang, Kun Shen, Si-Han Zhang, Yong-Mei He, Yan Ma & Ai-Hua Zhang. (2017) The preparation, characterization, structure and dissolution analysis of apremilast solvatomorphs. Acta Crystallographica Section C Structural Chemistry 73:4, pages 305-313.
Crossref
Crossref
Morgan E. Lawrenz, E. A. Salter, Andrzej Wierzbicki & W. J. Thompson. (2005) Molecular modeling study of binding to the catalytic site of PDE4 enzymes by a novel class of inhibitors. International Journal of Quantum Chemistry 105:4, pages 410-415.
Crossref
Crossref
Yaseen A. Al-Soud, Mohammad N. Al-Dweri & Najim A. Al-Masoudi. (2004) Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. Il Farmaco 59:10, pages 775-783.
Crossref
Crossref
Junghee Han, Ho-Chul Shin, Jong-Choon Kim & Byungbae Kim. (2004) Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs. Food and Chemical Toxicology 42:3, pages 373-380.
Crossref
Crossref
Tatsuzo Ukita, Masakatsu Sugahara, Yoshihiro Terakawa, Tooru Kuroda, Kazuteru Wada, Aya Nakata, Hideo Kikkawa, Katsuo Ikezawa & Kazuaki Naito. (2003) Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters 13:14, pages 2347-2350.
Crossref
Crossref
George M. Buckley, Nicola Cooper, Hazel J. Dyke, Fiona P. Galleway, Lewis Gowers, Alan F. Haughan, Hannah J. Kendall, Christopher Lowe, Robert Maxey, John G. Montana, Robert Naylor, Janet Oxford, Joanna C. Peake, C.Louise Picken, Karen A. Runcie, Verity Sabin, Andrew Sharpe & Julie B.H. Warneck. (2002) 8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters 12:12, pages 1613-1615.
Crossref
Crossref
George M Buckley, Nicola Cooper, Richard J Davenport, Hazel J Dyke, Fiona P Galleway, Lewis Gowers, Alan F Haughan, Hannah J Kendall, Christopher Lowe, John G Montana, Janet Oxford, Joanna C Peake, C.Louise Picken, Marianna D Richard, Verity Sabin, Andrew Sharpe & Julie B.H Warneck. (2002) 7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma. Bioorganic & Medicinal Chemistry Letters 12:3, pages 509-512.
Crossref
Crossref
George Buckley, Nicola Cooper, Hazel J Dyke, Fiona Galleway, Lewis Gowers, Joanna C Gregory, Duncan R Hannah, Alan F Haughan, Paul G Hellewell, Hannah J Kendall, Christopher Lowe, Robert Maxey, John G Montana, Robert Naylor, C.Louise Picken, Karen A Runcie, Verity Sabin, Bishwa R Tuladhar & Julie B.H Warneck. (2000) 7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters 10:18, pages 2137-2140.
Crossref
Crossref
John E. Souness, David Aldous & Carol Sargent. (2000) Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 47:2-3, pages 127-162.
Crossref
Crossref
Keith D Laemont, Caralee J Schaefer, Paul L Juneau & Denis J Schrier. (1999) Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats. International Journal of Immunopharmacology 21:11, pages 711-725.
Crossref
Crossref
Annette M Doherty. (1999) Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Current Opinion in Chemical Biology 3:4, pages 466-473.
Crossref
Crossref
Laura G. Corral, Patrick A. J. Haslett, George W. Muller, Roger Chen, Lu-Min Wong, Christopher J. Ocampo, Rebecca T. Patterson, David I. Stirling & Gilla Kaplan. (1999) Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α. The Journal of Immunology 163:1, pages 380-386.
Crossref
Crossref
D.G McGarry, J.R Regan, F.A Volz, C Hulme, K.J Moriarty, S.W Djuric, J.E Souness, B.E Miller, J.J Travis & D.M Sweeney. (1999) Benzofuran based PDE4 inhibitors. Bioorganic & Medicinal Chemistry 7:6, pages 1131-1139.
Crossref
Crossref
Robert D. Groneberg, Christopher J. Burns, Matthew M. Morrissette, John W. Ullrich, Robert L. Morris, Shelley Darnbrough, Stevan W. Djuric, Stephen M. Condon, Gerard M. McGeehan, Richard Labaudiniere, Kent Neuenschwander, Anthony C. Scotese & Jane A. Kline. (1999) Dual Inhibition of Phosphodiesterase 4 and Matrix Metalloproteinases by an (Arylsulfonyl)hydroxamic Acid Template. Journal of Medicinal Chemistry 42:4, pages 541-544.
Crossref
Crossref
John Regan, Joseph Bruno, Daniel McGarry, Gregory Poli, Barbara Hanney, Shelly Bower, Jeffrey Travis, Dennis Sweeney, Bruce Miller, John Souness & Stevan Djuric. (1998) 2-Substituted-4-methoxybenzimidazole-based PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters 8:19, pages 2737-2742.
Crossref
Crossref
Steven C. Beasley, Nicola Cooper, Lewis Gowers, Joanna P. Gregory, Alan F Haughan, Paul G. Hellewell, David Macari, Jadwiga Miotla, John G. Montana, Trevor Morgan, Robert Naylor, Karen A. Runcie, Bishwa Tuladhar & Julie B.H. Warneck. (1998) Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters 8:19, pages 2629-2634.
Crossref
Crossref
John E. Souness, Clare Houghton, Nughat Sardar & Michael T. Withnall. (2009) Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin‐2 release from murine splenocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer. British Journal of Pharmacology 121:4, pages 743-750.
Crossref
Crossref